Teva Pharmaceutical Industries (TEVA) Financial Analysis & Valuation | Quarter Chart

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, ... more
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, a... more

Company facts

Reported company information and share structure.

Company Share structure
Market Cap$49.67BExchangeNYSE
SectorHealthcareIndustryDrug Manufacturers - Specialty & Generic
CountryILCEORichard D. Francis
IPO Date1982-02-16CAGR14.01%
Employees32,008Websitewww.tevapharm.com
Div. Yield—Payout Ratio—
Buy Back Yield—Total Yield—
TEVA chart loading...

Key metrics

Reported fundamentals and market-derived technical indicators.

Fundamentals Technicals
EV$54.93BP/E14.53Forward P/E13.63PEG-2.15
P/S4.46P/B9.97P/CF40.74P/FCF57.37
Sales$17.31BSales 1Y4.13%Sales 3Y15.3%Sales 5Y6.07%
EPS$2.93EPS 1Y-475%EPS 3Y-129.74%EPS 5Y-116.81%
Sales QoQ4.04%EPS QoQ-258.06%Sales QoQ Avg0.25%EPS QoQ Avg-54.37%
Gross Margin52.47%Operating Margin11.45%Profit Margin4.08%ROCE8.19%
ROA2%ROE9%Altman Z Score0.95Piotroski Score7
Current Ratio0.88Quick Ratio0.67Cash Ratio0.23Op. CF Ratio0.03
Debt/Equity2.18Debt/Assets0.42Lt Debt/Equity1.6Lt Debt/Cap.0.61
Intrst Cov.2.2Inventory Turnover2.56Asset Turnover0.43Receivables Turnover4.96
Enterprise Value$54.93BP/E Ratio14.53
Forward P/E13.63PEG Ratio-2.15
P/S Ratio4.46P/B Ratio9.97
P/CF Ratio40.74P/FCF Ratio57.37
EPS$2.93EPS Growth 1Y-475%
EPS Growth 3Y-129.74%EPS Growth 5Y-116.81%
Revenue Growth 1Y4.13%Gross Margin52.47%
Operating Margin11.45%Profit Margin4.08%
ROE9%ROA2%
ROCE8.19%Current Ratio0.88
Quick Ratio0.67Cash Ratio0.23
Debt/Equity2.18Interest Coverage2.2
Altman Z Score0.95Piotroski Score7